Adipo Therapeutics
Transforming fat, changing lives
Transforming fat, changing lives
Adipo Therapeutics is a biotechnology startup based in Indiana, founded in 2017. The company focuses on developing polymer-based, Notch-inhibiting nanoparticles aimed at inducing browning in adipose (fat) tissue, effectively transforming white fat cells into beige adipocytes. This innovative approach targets weight reduction and the restoration of metabolic balance, particularly beneficial for individuals with diabetes.
The recent investment of $1.90M in the form of a Convertible Note at 31 January 2024 came from a consortium of investors including Elevate Ventures, VisionTech Partners, IU Angel Network, and the Purdue Research Foundation. This funding is expected to bolster Adipo Therapeutics' research and development efforts, potentially propelling the company towards significant advancements in the biotechnology and healthcare sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Convertible Note | $1.90M | 4 |
|
31 Jan 2024 |
| Seed Round | $100.00K | 1 |
|
22 Sep 2021 |
| Seed Round | $1.25M | - | 31 Aug 2020 |
No recent news or press coverage available for Adipo Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
